| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > The Role of Collaboration Technologies: Investing in the Personal Relationship |
|
Digg It - The Role of Collaboration Technologies: Investing in the Personal Relationship
Over the past several years the use of web-based collaboration tools, such as According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product web conferencing services and extranets, has grown dramatically in support o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in f the increasing number of work groups with geographically dispersed members. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. These tools have allowed organizations to tap the resources of employees, c here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe onsultants and vendors in real-time, regardless of their location. Additional d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y, they have dramatically decreased the cost of serving clients and made more ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc accessible a larger universe of prospective customers. But at what cost? Th easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e danger is that reliance on these tools may reduce the power of personal con nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tact. As the use of online collaboration to support relationships continues t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ o grow, it is critical that organizations integrate a personal touch. One st ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ategy is to re-invest the savings realized through the use of technology to s ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a upport travel expenses for occasional personal meetings. This provides the be dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod st of both worlds: the ability to move projects forward more rapidly using te cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin chnology, while exploiting the power of personal presence when required. The tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen net effect is that the cost to serve work groups and customers remains the s t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel me. But the benefit is that the proper mix can propel organizations to maximu ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust m efficiency and profitability. Simply pocketing the savings realized throug y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products h the use of web-based collaboration technology is a false profit. Putting a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de face on team participation and customer relationships is a critical investmen elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t in enhancing effective collaboration and maintaining stronger relationships tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Small Business Owners: The Benefits of Using a Voicemail Service
|